NO303777B1 - Analogi fremgangsmÕter til fremstilling av HIV-inhiberende benzenacetamidderivater, samt mellomprodukter - Google Patents

Analogi fremgangsmÕter til fremstilling av HIV-inhiberende benzenacetamidderivater, samt mellomprodukter

Info

Publication number
NO303777B1
NO303777B1 NO930047A NO930047A NO303777B1 NO 303777 B1 NO303777 B1 NO 303777B1 NO 930047 A NO930047 A NO 930047A NO 930047 A NO930047 A NO 930047A NO 303777 B1 NO303777 B1 NO 303777B1
Authority
NO
Norway
Prior art keywords
hiv
intermediates
inhibiting
preparation
well
Prior art date
Application number
NO930047A
Other languages
English (en)
Norwegian (no)
Other versions
NO930047D0 (no
NO930047L (no
Inventor
Georges Henri Paul Van Daele
Marc Gustaaf Celine Verdonck
Jean-Paul Renu Marie A Bosmans
Paul Adriaan Jan Janssen
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO930047D0 publication Critical patent/NO930047D0/no
Publication of NO930047L publication Critical patent/NO930047L/no
Publication of NO303777B1 publication Critical patent/NO303777B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/38—Amides of thiocarboxylic acids
    • C07C327/40—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C327/44—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/48—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72—Hydrazones
    • C07C251/86—Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C07C49/813—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
NO930047A 1990-07-10 1993-01-07 Analogi fremgangsmÕter til fremstilling av HIV-inhiberende benzenacetamidderivater, samt mellomprodukter NO303777B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP90201857 1990-07-10
EP91200646 1991-03-22
PCT/EP1991/001254 WO1992000952A1 (en) 1990-07-10 1991-07-04 Hiv-inhibiting benzeneacetamide derivatives

Publications (3)

Publication Number Publication Date
NO930047D0 NO930047D0 (no) 1993-01-07
NO930047L NO930047L (no) 1993-01-07
NO303777B1 true NO303777B1 (no) 1998-08-31

Family

ID=26125946

Family Applications (1)

Application Number Title Priority Date Filing Date
NO930047A NO303777B1 (no) 1990-07-10 1993-01-07 Analogi fremgangsmÕter til fremstilling av HIV-inhiberende benzenacetamidderivater, samt mellomprodukter

Country Status (42)

Country Link
US (2) US5556886A (enExample)
EP (1) EP0538301B1 (enExample)
JP (1) JPH0819068B2 (enExample)
KR (1) KR0183446B1 (enExample)
CN (2) CN1028990C (enExample)
AP (1) AP311A (enExample)
AT (1) ATE144765T1 (enExample)
AU (1) AU643056B2 (enExample)
BG (1) BG61809B1 (enExample)
CA (1) CA2084508A1 (enExample)
CZ (1) CZ279901B6 (enExample)
DE (1) DE69122963T2 (enExample)
DK (1) DK0538301T3 (enExample)
DZ (1) DZ1514A1 (enExample)
ES (1) ES2095942T3 (enExample)
FI (1) FI930070A0 (enExample)
GR (1) GR3021829T3 (enExample)
HR (1) HRP930485A2 (enExample)
HU (2) HUT64013A (enExample)
IE (1) IE75693B1 (enExample)
IL (3) IL111924A (enExample)
LT (1) LT3602B (enExample)
LV (1) LV10086B (enExample)
MA (1) MA22208A1 (enExample)
MX (1) MX9100100A (enExample)
MY (1) MY108580A (enExample)
NO (1) NO303777B1 (enExample)
NZ (1) NZ238763A (enExample)
OA (1) OA09770A (enExample)
PH (1) PH30977A (enExample)
PL (1) PL167076B1 (enExample)
PT (1) PT98259B (enExample)
RO (1) RO112855B1 (enExample)
RU (1) RU2087465C1 (enExample)
SG (1) SG48829A1 (enExample)
SI (1) SI9111204A (enExample)
SK (1) SK279639B6 (enExample)
TN (1) TNSN91056A1 (enExample)
TW (1) TW204337B (enExample)
WO (1) WO1992000952A1 (enExample)
YU (1) YU120491A (enExample)
ZA (1) ZA915334B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE149484T1 (de) * 1991-12-30 1997-03-15 Janssen Pharmaceutica Nv Alpha-substituierte benzenmethanamin-derivate
US6177435B1 (en) 1992-05-13 2001-01-23 Glaxo Wellcome Inc. Therapeutic combinations
ATE141254T1 (de) * 1992-07-06 1996-08-15 American Cyanamid Co O-nitrophenyl cyclopropyl keton, herbizides zwischenprodukt und verfahren zu seiner herstellung
EP0684818B1 (en) * 1993-02-22 1999-05-06 Janssen Pharmaceutica N.V. Method of reversing resistance of hiv-1 strains to zidovudine
US5767310A (en) * 1993-03-19 1998-06-16 Merck & Co., Inc. Phenoxyphenylacetic acid derivatives
US5686478A (en) * 1993-07-20 1997-11-11 Merck & Co. Inc. Endothelin antagonists
GB9403449D0 (en) * 1994-02-23 1994-04-13 Wellcome Found Therapeutic benzonitriles
GB9403408D0 (en) * 1994-02-23 1994-04-13 Wellcome Found Therapeutic benzonitriles
IL112739A0 (en) * 1994-02-23 1995-05-26 Wellcome Found Ayrlthiobenzonitrile compounds, their preparation and pharmaceutical compositions containing them
US5538991A (en) * 1994-09-14 1996-07-23 Merck & Co., Inc. Endothelin antagonists bearing 5-membered heterocyclic amides
US5559135A (en) * 1994-09-14 1996-09-24 Merck & Co., Inc. Endothelin antagonists bearing pyridyl amides
EP0872233A1 (en) * 1997-04-14 1998-10-21 Janssen Pharmaceutica N.V. Antiretroviral compositions with improved bioavailability
KR100554815B1 (ko) * 1997-08-22 2006-02-22 에프. 호프만-라 로슈 아게 엔-아로일페닐알라닌 유도체
WO1999065871A2 (en) * 1998-06-19 1999-12-23 The Government Of The United States Of America Represented By The Secretary, Department Of Health And Human Services Thiolesters and uses thereof
TR200200763T2 (tr) 1999-09-24 2003-09-22 Janssen Pharmaceutica N.V. Antiviral bileşimler
US6916956B2 (en) 2000-08-11 2005-07-12 Japan Tobacco, Inc. Calcium receptor antagonist
AU2005235692B2 (en) * 2004-04-23 2011-11-10 F. Hoffmann-La Roche Ag Non-nucleoside reverse transcriptase inhibitors
US7625949B2 (en) 2004-04-23 2009-12-01 Roche Palo Alto Llc Methods for treating retroviral infections
EP2061756B1 (en) * 2006-06-08 2013-09-25 Bristol-Myers Squibb Company 2-aminocarbonylphenylamino-2-phenilacetamides as factor viia inhibitors useful as anticoagulants
RU2449985C2 (ru) * 2010-03-31 2012-05-10 Федеральное государственное унитарное предприятие "Российский научный центр "Прикладная химия" Способ получения n,n-диметилацетамида
CN102675212B (zh) * 2012-05-09 2014-11-05 昆明理工大学 N-取代苯基-2-((1h-苯并咪唑-2-基)巯基)乙酰胺类衍生物及其用途
CN104000807B (zh) * 2014-05-28 2016-05-18 中山大学 苯基-酰胺类化合物在制备抗hiv-1病毒药物中的应用
CN105367437B (zh) * 2015-10-12 2017-08-01 湖北文理学院 一种2‑芳氨基乙酰胺类化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1423430A (en) * 1973-03-29 1976-02-04 Wyeth John & Brother Ltd Thioamides
US4246429A (en) * 1978-06-23 1981-01-20 Janssen Pharmaceutica, N.V. Novel α-amino-phenylacetic acid derivatives
CH637828A5 (en) * 1978-11-15 1983-08-31 Koehler Franz Dr Chemie Kg Cytostatics
ATE149484T1 (de) * 1991-12-30 1997-03-15 Janssen Pharmaceutica Nv Alpha-substituierte benzenmethanamin-derivate

Also Published As

Publication number Publication date
LT3602B (en) 1995-12-27
DK0538301T3 (da) 1996-11-25
MX9100100A (es) 1992-02-28
EP0538301B1 (en) 1996-10-30
US5684049A (en) 1997-11-04
IE75693B1 (en) 1997-09-10
PH30977A (en) 1997-12-23
TW204337B (enExample) 1993-04-21
SI9111204A (en) 1995-04-30
BG97265A (bg) 1994-03-24
JPH0819068B2 (ja) 1996-02-28
PL297608A1 (enExample) 1992-07-13
CN1107835A (zh) 1995-09-06
IL98756A (en) 1996-06-18
WO1992000952A1 (en) 1992-01-23
ATE144765T1 (de) 1996-11-15
AU643056B2 (en) 1993-11-04
ZA915334B (en) 1993-03-31
FI930070A7 (fi) 1993-01-08
LV10086B (en) 1995-02-20
NO930047D0 (no) 1993-01-07
IE912208A1 (en) 1992-01-15
JPH05507931A (ja) 1993-11-11
US5556886A (en) 1996-09-17
PL167076B1 (pl) 1995-07-31
MY108580A (en) 1996-10-31
CN1033142C (zh) 1996-10-30
PT98259A (pt) 1992-04-30
NZ238763A (en) 1993-10-26
LTIP848A (en) 1995-02-27
NO930047L (no) 1993-01-07
RU2087465C1 (ru) 1997-08-20
HU211873A9 (en) 1995-12-28
AU8212091A (en) 1992-02-04
LV10086A (lv) 1994-05-10
AP311A (en) 1994-02-01
CN1058958A (zh) 1992-02-26
HUT64013A (en) 1993-11-29
IL111924A0 (en) 1995-03-15
SK210291A3 (en) 1995-07-11
ES2095942T3 (es) 1997-03-01
KR0183446B1 (ko) 1999-05-15
CS210291A3 (en) 1992-02-19
HRP930485A2 (en) 1996-06-30
DE69122963T2 (de) 1997-03-13
FI930070A0 (fi) 1993-01-08
PT98259B (pt) 1998-12-31
DE69122963D1 (de) 1996-12-05
HU9300032D0 (en) 1993-04-28
DZ1514A1 (fr) 2004-09-13
CZ279901B6 (cs) 1995-08-16
OA09770A (fr) 1993-11-30
MA22208A1 (fr) 1992-04-01
IL111924A (en) 1996-12-05
SG48829A1 (en) 1998-05-18
CA2084508A1 (en) 1992-01-11
AP9100288A0 (en) 1991-07-31
GR3021829T3 (en) 1997-02-28
IL98756A0 (en) 1992-07-15
TNSN91056A1 (fr) 1992-10-25
CN1028990C (zh) 1995-06-21
YU120491A (sh) 1994-06-10
SK279639B6 (sk) 1999-01-11
BG61809B1 (bg) 1998-06-30
EP0538301A1 (en) 1993-04-28
RO112855B1 (ro) 1998-01-30

Similar Documents

Publication Publication Date Title
NO904987D0 (no) Fremgangsmaate for fremstilling av indolderivater.
NO913234D0 (no) Fremgangsmaate for fremstilling av pyrazolderivater.
NO905255L (no) Fremgangsmaate for fremstilling av heterocyklisk substituerte acylaminotiazoler.
NO912051D0 (no) Fremgangsmaate for fremstilling av azolderivater.
NO913008D0 (no) Fremgangsmaate for fremstilling av fenylacetamid-derivater.
NO905008D0 (no) Fremgangsmaate for fremstilling av heterocykliske forbindelser.
NO904285L (no) Fremgangsmaate for fremstilling av substituerte karboksytetrahydroisokinoliner.
NO903431D0 (no) Fremgangsmaate for fremstilling av kromanderivater.
NO903275D0 (no) Fremgangsmaate for fremstilling av kromanderivater.
NO903043L (no) Fremgangsmaate for fremstilling av kromanderivater.
NO901813D0 (no) Fremgangsmaate for fremstilling av nye tieno-triazolo-diazepin-derivater.
NO905377L (no) Fremgangsmaate for fremstilling av glycerolderivater.
NO905444D0 (no) Fremgangsmaate til fremstilling av oksazolderivater.
NO913391D0 (no) Fremgangsmaate for fremstilling av nye hetrazepinoide syreamider.
FI904676A0 (fi) Anordning foer loesgoerande av manteln i en haeftapparat.
NO903207D0 (no) Fremgangsmaate for fremstilling av halogenaminoaromatiske derivater.
NO901690D0 (no) Fremgangsmaate til fremstilling av substituerte azetidinylisotiazolpyridon-derivater.
FI891257A0 (fi) Foerfarande och anordning foer framstaellning av marinbyggnadskonstruktioner, saosom bropelare, bryggor och liknande.
NO911118D0 (no) Fremgangsmaate for fremstilling av nye 8-sulfamylmethylen-2-amino-tetraliner.
NO900969D0 (no) Fremgangsmaate for fremstilling av anilin-derivat.
NO902762D0 (no) Fremgangsmaate for fremstilling av 5-fenyl-2-furan derivater.
NO904060L (no) Fremgangsmaate for fremstilling av substituerte dibenzofuraner.
NO911672D0 (no) Fremgangsmaate for fremstilling av alkansulfonanilid-derivater.
NO900381D0 (no) Fremgangsmaate for fremstilling av nafthalenderivater.
NO905047D0 (no) Fremgangsmaate for fremstilling av selenofenderivater.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JANUARY 2001